Early Detection, A New Cancer Screening Test Can Identify All Forms of Cancer At Earliest Stage

DALLAS - March 18, 2013 - PRLog -- ONCOblot® Test, a highly sensitive blood test for cancer, is now available for use by physicians across the United States; bringing much needed support to the phrase “early detection is key”.

The ONCOblot®  Test, one of the latest test for cancer,  was developed by Mor-NuCo in West Lafayette, Indiana, ONCOblot® is a Laboratory Developed Test, CLIA and CAP accredited, and has the power to catch all forms of known cancer at their absolute earliest stage of detection.

The test works by locating and identifying the ENOX 2 proteins in the blood, which are unique to malignant cancer cells. Based on the type of ENOX 2 protein identified, the ONCOblot® Test reveals the host site organ, and stage of cancer.

“Our test is the most sensitive blood test for cancer available today,” says ONCOblot® Test researcher and developer, Dr. Jim Morre’, CEO and Director of Research, Mor-NuCo, LLC. “ONCOblot® detects a cancer of 2 million cells compared to 4.5 trillion cells in a positive mammogram,” he continued.

In addition to the basic function of identifying the presence of cancer, the ONCOblot® Test also screens for origin of cancer, recurrence of cancer, familial cancer, and the presence of malignant cells while undergoing treatments for cancer.

ONCOblot® Test, one of the latest blood tests for cancer, is a key component to treating cancer because it gives patients and physicians the insights for successful cancer management. Never before has one test been able to detect cancer on such a micro level and provide so much knowledge for early intervention and on-going management.  

About ONCOblot®

The ONCOblot® Test was developed and created by Dr. D. James Morre’ and Dr. Dorothy M. Morre’ of Mor-NuCo, Purdue Research Park, West Lafayette, IN. The Morre’s are committed to the premise that understanding cancer is the key to its conquest.  The ONCOblot® test is based on more than 20 years of basic research.  

If you’d like more information about the ONCOblot® Test, please visit ONCOblot Labs, or visit our Test Kit for Cancer